Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.
NCT01123434
·
clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
2 Years PSA Recurrence Rate
Sponsor
AstraZeneca